The effects of evening primrose oil in preparing the cervix before hysteroscopic surgeries
Phase 3
- Conditions
- Hysteroscopy.
- Registration Number
- IRCT20230404057817N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Menopausal women or women of reproductive age with no history of normal vaginal delivery (NVD)
Closure of the cervix
Exclusion Criteria
Women with cervical structural abnormalities and a history of cervical insufficiency
Women with Müller malformations
Women with a history of conization
Women with any contraindications to EPO or misoprostol (EPO or misoprostol contraindications such as seizures, asthma, high blood pressure, glaucoma, etc.)
Women who have a history of failed hysteroscopy or D&C due to severe cervical stenosis.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time to reach the required dilatation (3 to 7 mm). Timepoint: From the start of the operation until reaching the required expansion. Method of measurement: Clinical.
- Secondary Outcome Measures
Name Time Method Cervical rupture. Timepoint: Immediately after the patient regains consciousness. Method of measurement: Clinical observations.;Perforation of the uterus. Timepoint: Immediately after the patient regains consciousness. Method of measurement: Clinical observations.;Side effects. Timepoint: Immediately after the patient regains consciousness. Method of measurement: Clinical observations.